logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. St. Olav's University Hospital

+4772573000
post@stolav.no
Source: Site record.
https://www.stolav.no

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

St. Olav's University Hospital, located at Prinsesse Kristinas gate 3 in Trondheim, Norway, is one of the country's largest and most advanced medical institutions. The hospital is fully integrated with the Norwegian University of Science and Technology (NTNU), blending specialized patient treatment, world-class medical research, and clinical education within a highly sustainable, urban quarter-style campus.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Hospital

Business Subcategory

Source: Google. Hospital
Source: Google. University hospital
Source: Trial-derived.
86Total Trials
Source: Trial-derived.
18Recruiting Trials
Source: Trial-derived.
26Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
126Unique Conditions
Source: Trial-derived.
175Unique Sponsors

Conditions

Source: Trial-derived. Multiple Myeloma (4)Source: Trial-derived. Breast Cancer (2)Source: Trial-derived. Colorectal Cancer (2)Source: Trial-derived. Follicular Lymphoma (2)Source: Trial-derived. Leukemia, Acute Lymphoblastic (2)Source: Trial-derived. Lung Cancer (2)Source: Trial-derived. Mantle Cell Lymphoma (2)Source: Trial-derived. Multiple Sclerosis (2)

Sponsors

Source: Trial-derived. St. Olavs Hospital (34)Source: Trial-derived. Oslo University Hospital (19)Source: Trial-derived. Haukeland University Hospital (17)Source: Trial-derived. Norwegian University of Science and Technology (17)Source: Trial-derived. University Hospital of North Norway (15)Source: Trial-derived. Helse Stavanger HF (8)Source: Trial-derived. Merck Sharp & Dohme LLC (8)Source: Trial-derived. University Hospital, Akershus (8)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. PET-CT
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Stereotactic body radiotherapy (SBRT)